Chronic Eosinophilic Leukemia, Not Otherwise Specified
chronic myelogenous leukemia +
Chronic Neutrophilic Leukemia
cirrhosis of liver +
endomyocardial fibrosis
erythroid neoplasm +
essential thrombocythemia
idiopathic aplastic anemia +
inherited aplastic anemia +
Myelodysplastic/Myeloproliferative Neoplasm +
myelofibrosis
myeloid leukemia +
myeloproliferative neoplasm, unclassifiable
paroxysmal nocturnal hemoglobinuria +
Peritoneal Fibrosis
polycythemia vera
primary acquired red cell aplasia +
primary myelofibrosis +
Myelofibrosis with myeloid metaplasia is a myeloproliferative disease with annual incidence of approximately 1 case per 100,000 individuals and age at diagnosis around 60 (an increased prevalence is noted in Ashkenazi Jews). Clinical manifestations depend on the type of blood cell affected and may include anemia, pallor, splenomegaly, hypermetabolic state, petechiae, ecchymosis, bleeding, lymphadenopathy, hepatomegaly, portal hypertension.